Results 141 to 150 of about 13,290 (176)
Some of the next articles are maybe not open access.
Pneumocystis jirovecii genotypes and granulomatous pneumocystosis
Médecine et Maladies Infectieuses, 2006This study describes the initial data concerning molecular typing of Pneumocystis jirovecii in a patient having developed granulomatous Pneumocystis pneumonia (PCP). Three types, B(1)a(3), B(1)a(4), B(1)b(2), were identified. All three had been described in reports concerning patients with common diffuse alveolar PCP.
Totet, A. +5 more
openaire +3 more sources
Pneumocystis jirovecii Pneumonia
2020The life cycle of Pneumocystis jirovecii is complicated. It tries to find a damaged immune system to replicate, leading to life-threatening complications. With the treatment of immunosuppressive drugs, Pneumocystis jirovecii pneumonia has become a common opportunistic infection in non-AIDS populations. A CD4+ lymphocyte count of
Jing Feng +4 more
openaire +1 more source
Pneumocystis jirovecii and Pneumocystosis
2017Pneumocystis jirovecii pneumonia (PcP or pneumocystosis) remains a major cause of respiratory illness among immunocompromised patients, especially those infected with the human immunodeficiency virus (HIV). P. jirovecii infection has also been detected in healthy individuals and people with chronic lung diseases, raising the possibility that the ...
Olga Matos +2 more
openaire +1 more source
Pneumocystis jirovecii (carinii)
2015This chapter cites Pneumocystis jirovecii (PJP), formerly known as Pneumocystis carinii, as an opportunistic pathogen that causes pneumonia in the immunocompromised individual. It explains how the disease caused by PJP occurs when both cellular and humoral immunity are impaired.
Shelley A. Gilroy, Nicholas J. Bennett
openaire +1 more source
Pneumocystis jirovecii: a review with a focus on prevention and treatment
Expert Opinion on Pharmacotherapy, 2021CARLOS Cervera +2 more
exaly
Non-invasive diagnosis of Pneumocystis jirovecii pneumonia: a systematic review and meta-analysis
Clinical Microbiology and Infection, 2022Guillaume Butler-Laporte +2 more
exaly